Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

POSKX vs CANC overlap: 17% of top holdings shared

Bottom line

How much do POSKX and CANC overlap?

17% of their top holdings overlap by weight. 4 securities appear in both funds' top 25, making up 12.3% of POSKX's assets and 13.8% of CANC's. They are substantially different portfolios, so owning both adds real diversification.

POSKX holds far more positions (149 vs 57), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

POSKXCANC
Weight overlap (top 25)17%
Shared holdings4
Weight in shared holdings12.3%13.8%
Total positions14957
Expense ratio0.67%0.75%
Holdings as ofJul 31, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Holdings POSKX and CANC have in common

Holding% of POSKX% of CANCOverlap
Eli Lilly & Co LLY5.54%4.82%4.82%
AstraZeneca PLC AZN3.43%3.54%3.43%
Bristol-Myers Squibb Co BMY1.75%3.30%1.75%
Amgen Inc AMGN1.60%2.11%1.60%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in POSKX

  1. Intel Corp — 7.41%
  2. Flex Ltd — 3.34%
  3. KLA Corp — 2.75%
  4. Siemens AG — 2.53%
  5. Ross Stores Inc — 2.42%
  6. Microsoft Corp — 2.38%
  7. Biogen Inc — 2.34%
  8. FedEx Corp — 1.85%
  9. Aecom — 1.69%
  10. Southwest Airlines Co — 1.58%
  11. United Airlines Holdings Inc — 1.56%
  12. Elanco Animal Health Inc — 1.53%
  13. Curtiss-Wright Corp — 1.41%
  14. Applied Materials Inc — 1.37%
  15. Northern Trust Corp — 1.31%

Only in CANC

  1. Revolution Medicines Inc — 7.73%
  2. Roche Holding AG — 4.21%
  3. Cogent Biosciences Inc — 4.10%
  4. Novartis AG — 4.03%
  5. Immunome Inc — 3.91%
  6. Celcuity Inc — 3.58%
  7. Merck & Co Inc — 3.57%
  8. Nuvalent Inc — 3.37%
  9. Legend Biotech Corp — 2.99%
  10. AbbVie Inc — 2.81%
  11. Exelixis Inc — 2.78%
  12. Bridgebio Pharma Inc — 2.75%
  13. Johnson & Johnson — 2.55%
  14. CG oncology Inc — 2.43%
  15. Genmab A/S — 2.37%

Asset mix

Asset typePOSKXCANC
Stocks98.2%99.0%
Cash & short-term funds1.8%1.1%

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Country mix

CountryPOSKXCANC
US87.6%80.9%
CH1.0%8.2%
GB5.2%4.0%
DE3.3%1.1%
DK—2.4%
CN—2.0%
JP1.6%0.7%
NL0.6%—

Source: SEC Form N-PORT (periods Jul 31, 2026 / May 31, 2026)

Check another pair

FAQ

How much do POSKX and CANC overlap?
About 17% by weight. 4 securities appear in both funds' top 25 holdings; they make up 12.3% of POSKX's assets and 13.8% of CANC's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do POSKX and CANC have in common?
The largest shared holdings are Eli Lilly & Co, AstraZeneca PLC, Bristol-Myers Squibb Co, Amgen Inc.
Should I own both POSKX and CANC?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, POSKX or CANC?
POSKX is broader, with 149 positions versus 57 for CANC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.